The original HyperX Cloud Mix Buds were nifty gaming earbuds with batteries that could survive 10-hour sessions. For the follow-up HyperX has swapped that juice – they now last just seven hours – for ...
A phase I clinical study to evaluate the safety, tolerability, and pharmacokinetic characteristics of HLX43 (anti-PD-L1 ADC) in patients with advanced/metastatic solid tumors. Association of genomic ...
TL;DR: Thunderobot's MIX GAMING 2 Mini-PC, showcased at CES 2026, delivers powerful 4K @ 120FPS gaming with up to an Intel Core Ultra 9 275HX CPU and NVIDIA GeForce RTX 5090 GPU. It features advanced ...
The biggest stories of the day delivered to your inbox.
Michael Block is a 14 time GLAM Award nominated writer, producer, and host of the podcast Block Talk. Throughout his time in the entertainment industry, he has worked on and off Broadway as a stage ...
More antibodies take aim at seeded propagation. New data ties tangle location to deficits in specific cognitive domains. Three first-in-human studies for antibodies targeting different parts of tau ...
LAWRENCE, Kan. (KCTV) - The next phase of the University of Kansas’ renovation of David Booth Kansas Memorial Stadium and the accompanying Gateway District project is underway. Construction crews ...
The body of just one Israeli hostage remains in Gaza, nearing the fulfillment of a key plank of President Donald Trump’s 20-point ceasefire plan for the enclave, but major hurdles exist to a planned ...
Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) released topline data on Wednesday from its Phase 2 trial of silevertinib in frontline (1L) non-small cell lung cancer (NSCLC) patients with ...
Eni SpA said Tuesday the second phase of Congo LNG in the Republic of the Congo has started operations, bringing the project's capacity to three million metric tons per annum (MMtpa) of liquefied ...
Ever heard of making cake with just a can of pop and a boxed cake mix? It sounds wild, but it really works! There’s no need for eggs or oil—just two simple ingredients and your oven. The result is a ...
Both tobevibart (a monoclonal antibody) and elebsiran (a small interfering RNA) target hepatitis B virus surface antigen (HBsAg). Their efficacy and safety in the treatment of chronic hepatitis D ...